In 2011, Samaropoulos and coworkers demonstrated how an intensive glycemic control in middle- to old-aged type 2 diabetic patients, who already had or are at risk for cardiovascular disease, was associated with a reduction in high-sensitivity C-reactive protein (hs-CRP) [46]. The gene discussed is CRP; the disease is cardiovascular disorder.